Sort
15,842 grants matching “pancreatic cancer”
Fingerprinting Invasive Membrane Protrusions to Discover Metastatic Signatures
$378,402Richard L. Klemke · University Of California, San Diego · R01 · FY2015 · CA
Fingerprinting Invasive Membrane Protrusions to Discover Metastatic Signatures
$378,402Richard L. Klemke · University Of California, San Diego · R01 · FY2016 · CA
Fingerprinting Invasive Membrane Protrusions to Discover Metastatic Signatures
$378,402Richard L. Klemke · University Of California, San Diego · R01 · FY2014 · CA
Exploiting Caveolae-Dependent Albumin Endocytosis to Optimize Therapy in Pancreatic Cancer
$378,304Terence Marques Williams · Ohio State University · R01 · FY2019 · CA
Theranostic nanoparticles for detection and treatment of pancreatic cancer
$378,267Lacey R McNally · Wake Forest University Health Sciences · R01 · FY2018 · EB
Role of SETD5 in Chromatin Regulation and Tumorigenesis
$378,256Pawel K. Mazur · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Targeting the liver for immunotherapy in pancreatic cancer
$378,219Gregory L Beatty · University Of Pennsylvania · R01 · FY2023 · CA
Cell-Surface Interactions in Pathogenesis
$378,203Kenneth Yamada · National Institute Of Dental & Craniofacial Research · ZIA · FY2014 · DE
The role of fibroblasts in the activities of tissue penetrating peptides
$378,202Kazuki Sugahara · Columbia University Health Sciences · R01 · FY2015 · CA
The role of fibroblasts in the activities of tissue penetrating peptides
$378,202Kazuki Sugahara · Columbia University Health Sciences · R01 · FY2016 · CA
Dosage-Dependent Hedgehog Signaling in Pancreatic Cancer
$378,171Benjamin Allen · University Of Michigan At Ann Arbor · R01 · FY2018 · CA
Dosage-Dependent Hedgehog Signaling in Pancreatic Cancer
$378,171Benjamin Allen · University Of Michigan At Ann Arbor · R01 · FY2017 · CA
Vascularized tumor explants for drug testing
$378,078Lance L Munn · Massachusetts General Hospital · R01 · FY2025 · CA
Vascularized tumor explants for drug testing
$378,078Lance L Munn · Massachusetts General Hospital · R01 · FY2021 · CA
Structural Biology Shared Facility
$377,961William J. Placzek · University Of Alabama At Birmingham · P30 · FY2021 · CA
Understanding optimal delivery systems for cancer care
$377,902David C Miller · University Of Michigan At Ann Arbor · R01 · FY2015 · CA
Multifunctional immunoPET tracers for pancreatic and prostate cancer
$377,890Anna M Wu · Beckman Research Institute/City Of Hope · R01 · FY2018 · CA
Education Program in Cancer Prevention
$377,886Joel L Weissfeld · University Of Pittsburgh At Pittsburgh · R25 · FY2008 · CA
A HTS Approach to Discover Guanine Nucleotide-Competitive Inhibitors of Oncogenic KRAS
$377,858Kent Rossman · Univ Of North Carolina Chapel Hill · R01 · FY2019 · CA
Metabolic vulnerability due to dysregulated lipid metabolism in PDAC cachexia
$377,780Aaron Grossberg · Oregon Health & Science University · R37 · FY2025 · CA
RTB 1
$377,742Laura Delong Wood · Johns Hopkins University · U54 · FY2022 · CA
Treatment of Hypoxia Resistance in Pancreatic Cancer - Clinical
$377,705Tomislav Dragovich · Translational Genomics Research Inst · P01 · FY2006 · CA
Understanding optimal delivery systems for cancer care
$377,699David C Miller · University Of Michigan At Ann Arbor · R01 · FY2017 · CA
Understanding optimal delivery systems for cancer care
$377,699David C Miller · University Of Michigan At Ann Arbor · R01 · FY2016 · CA
Novobiocin-mediated polymerase theta inhibition in homologous recombination repair-deficient cancers
$377,516Geoffrey I Shapiro · Dana-Farber Cancer Inst · R01 · FY2024 · CA